Cencora, Inc. Files 8-K: Board Changes & Executive Compensation Updates
Ticker: COR · Form: 8-K · Filed: Mar 12, 2024 · CIK: 1140859
| Field | Detail |
|---|---|
| Company | Cencora, INC. (COR) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
Related Tickers: ABC
TL;DR
Cencora (ABC) filed an 8-K: new directors elected, exec comp updated.
AI Summary
On March 11, 2024, Cencora, Inc. (formerly AmerisourceBergen Corp) filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing includes the election of new directors and updates to compensatory plans for its officers.
Why It Matters
This filing signals potential shifts in corporate governance and executive incentives at Cencora, which could influence investor confidence and strategic direction.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance matters and executive compensation, which typically carry low immediate risk.
Key Players & Entities
- Cencora, Inc. (company) — Registrant
- AmerisourceBergen Corp (company) — Former company name
- March 11, 2024 (date) — Date of earliest event reported
FAQ
What specific changes were made to Cencora's board of directors?
The filing indicates the election of new directors, though specific names and details of their appointments are not provided in the initial summary.
What type of compensatory arrangements were updated for Cencora's officers?
The filing mentions updates to compensatory arrangements for certain officers, but the specific details of these arrangements are not elaborated upon in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on March 11, 2024.
What is Cencora, Inc.'s former name?
Cencora, Inc.'s former name was AmerisourceBergen Corp.
What is Cencora, Inc.'s Commission File Number?
Cencora, Inc.'s Commission File Number is 1-6671.
Filing Stats: 737 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2024-03-12 08:46:06
Filing Documents
- tm248543d1_8k.htm (8-K) — 28KB
- tm248543d1_ex99-1.htm (EX-99.1) — 18KB
- tm248543d1_ex99-1img001.jpg (GRAPHIC) — 19KB
- 0001104659-24-033278.txt ( ) — 245KB
- cor-20240311.xsd (EX-101.SCH) — 3KB
- cor-20240311_lab.xml (EX-101.LAB) — 33KB
- cor-20240311_pre.xml (EX-101.PRE) — 22KB
- tm248543d1_8k_htm.xml (XML) — 3KB
02 Departure
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. On March 11, 2024, the Board of Directors (the "Board") of Cencora, Inc. (the "Company") unanimously selected Robert P. Mauch to succeed Steven H. Collis as the Company's President and Chief Executive Officer ("CEO"), effective October 1, 2024 (the "Effective Date"), at which time he will also join the Board. Mr. Collis, who has served as CEO since July 2011, will retire from the role of CEO and become Executive Chairman of the Board as of the Effective Date, to serve for a period of one year. Mr. Mauch, age 57, currently serves as the Company's Executive Vice President and Chief Operating Officer. He previously served as the Company's Group President from February 2019 to September 2022 and as Group President, Pharmaceutical Distribution & Strategic Global Sourcing from June 2017 to February 2019. Mr. Mauch joined the Company in 2007 when it acquired Xcenda and has since held various leadership roles. Mr. Mauch will not receive any additional compensation for his service on the Board. The Company will file an amendment to this Current Report on Form 8-K to disclose compensation arrangements relating to the foregoing events within four business days after such information becomes available.
01 Regulation
Item 7.01 Regulation FD Disclosure. On March 12, 2024, the Company issued a press release announcing the CEO transition described under Item 5.02 of this Current Report on Form 8-K and reaffirming its fiscal 2024 guidance as outlined on January 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this
01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes
Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.
01 Financial
Item 9.01 Financial (d) Exhibits. Exhibit Number Description 99.1 News release of Cencora, Inc., dated March 12, 2024. 104 Cover Page Interactive Data File (formatted as inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cencora, Inc. March 12, 2024 By: /s/ Elizabeth S. Campbell Name: Elizabeth S. Campbell Title: Executive Vice President and Chief Legal Officer